A Single-Center Long-Term Continuous Subcutaneous Insulin Infusion (CSII) Experience: Higher Fractional Use Is Associated With Less Diabetes Complications
- PMID: 28367635
- PMCID: PMC5950992
- DOI: 10.1177/1932296817702170
A Single-Center Long-Term Continuous Subcutaneous Insulin Infusion (CSII) Experience: Higher Fractional Use Is Associated With Less Diabetes Complications
Keywords: diabetes complications; insulin pumps; long-term continuous subcutaneous insulin infusion; type 1 diabetes.
Conflict of interest statement
Figures
Similar articles
-
Continuous subcutaneous insulin infusion (CSII) pumps.Adv Exp Med Biol. 2012;771:414-9. doi: 10.1007/978-1-4614-5441-0_29. Adv Exp Med Biol. 2012. PMID: 23393693 Review.
-
Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).Diabetes Metab. 2011 Nov;37(5):426-31. doi: 10.1016/j.diabet.2011.02.002. Epub 2011 Apr 6. Diabetes Metab. 2011. PMID: 21474360
-
Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.J Diabetes Sci Technol. 2017 May;11(3):631-632. doi: 10.1177/1932296816668375. Epub 2016 Sep 5. J Diabetes Sci Technol. 2017. PMID: 27595713 Free PMC article. No abstract available.
-
Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.Exp Clin Endocrinol Diabetes. 2015 Apr;123(4):260-4. doi: 10.1055/s-0034-1394381. Epub 2015 Jan 21. Exp Clin Endocrinol Diabetes. 2015. PMID: 25607337
-
[The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].Wiad Lek. 2004;57(5-6):263-6. Wiad Lek. 2004. PMID: 15518073 Review. Polish.
Cited by
-
Predictive Low Glucose Suspend Algorithm in Real Life: A Five-Year Follow-Up Retrospective Analysis.J Diabetes Sci Technol. 2021 Nov;15(6):1303-1307. doi: 10.1177/1932296820952107. Epub 2020 Aug 29. J Diabetes Sci Technol. 2021. PMID: 32865016 Free PMC article.
-
Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy.Int J Mol Sci. 2023 Jul 26;24(15):11980. doi: 10.3390/ijms241511980. Int J Mol Sci. 2023. PMID: 37569354 Free PMC article. Review.
-
In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time.J Diabetes Sci Technol. 2023 Nov;17(6):1563-1572. doi: 10.1177/19322968221093362. Epub 2022 May 9. J Diabetes Sci Technol. 2023. PMID: 35533132 Free PMC article.
-
Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits.Curr Cardiol Rep. 2022 Dec;24(12):2043-2056. doi: 10.1007/s11886-022-01799-x. Epub 2022 Oct 24. Curr Cardiol Rep. 2022. PMID: 36279036 Free PMC article. Review.
References
-
- Petrie D, Lung TWC, Rawshani A, et al. Recent trends in life expectancy for people with type 1 diabetes in Sweden. Diabetologia. 2016;59:1167-1176. - PubMed
-
- Misso ML, Egberts KJ, Page M, O’Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010;(1):CD005103. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical